Prior PCa Tx does not preclude abiraterone use.

Detalles Bibliográficos
Publicado en:Urology Times Vol. 39; no. 12; p. 29
Autor principal: Krader, Cheryl Guttman
Formato: brief item pictorial Journal Article
Publicado: MJH Life Sciences Nov2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=67306547&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 67306547
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: Nov2011
      vid: 39
      iid: 12
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        67306547
        67306547
        108226556
        67306547
      ppf: 29
      ppct: 0
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Prior PCa Tx does not preclude abiraterone use.
      aug:
        au: Krader, Cheryl Guttman
      sug:
        subj:
          Prostatic Neoplasms Drug Therapy
          Androstenedione Administration and Dosage
          Male
          Protocols
          Male
      pubtype: Academic Journal
      doctype:
        brief item
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N